COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,252 Articles (22,236 medRxiv, 8,016 bioRxiv)

Most recent first Previous |  Page 439: Articles 4381-4390  | Next

Transgenic Mouse Models Establish a Protective Role of Type 1 IFN Response in SARS-CoV-2 infection-related Immunopathology
Chauhan, N. R., Kundu, S., Bal, R., Chattopadhyay, D., Mehto, S., Sahu, R., Yadav, R., Krishna, S., Jena, K. K., Satapathy, S., Murmu, K. C., Singh, B., Das, S. K., Jena, S., Harshan, K. H., Syed, G. H., Prasad, P., Chauhan, S.
10.1101/2022.12.17.520843 — Posted: 2022-12-19
A retrospective analysis of COVID-19 non-pharmaceutical interventions for Mexico and Peru: a modeling study
Acuna-Zegarra, M. A., Santana-Cibrian, M., Rodriguez Hernandez-Vela, C. E., Mena, R. H., Velasco-Hernandez, J. X.
10.1101/2022.12.19.22283668 — Posted: 2022-12-19
Association between SARS-CoV-2 Infection and Select Symptoms and Conditions 31 to 150 Days After Testing among Children and Adults
Zhang, Y., Romieu-Hernandez, A., Boehmer, T. K., Azziz-Baumgartner, E., Carton, T., Gundlapalli, A. V., Fearrington, J., Nagavedu, K., Dea, K., Moyneur, E., Cowell, L. G., Kaushal, R., Mayer, K. H., Puro, J., Rasmussen, S. A., Thacker, D., Weiner, M. G., Saydeh, S., Block, J. P.
10.1101/2022.12.18.22283646 — Posted: 2022-12-19
Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine
Shrestha, N. K., Burke, P. C., Nowacki, A. S., Simon, J. F., Hagen, A., Gordon, S. M.
10.1101/2022.12.17.22283625 — Posted: 2022-12-19
Digital PCR discriminates between SARS-CoV-2 Omicron variants and immune escape mutations
Holland, S. C., Holland, L. A., Smith, M. F., Lee, M. B., Hu, J. C., Lim, E. S.
10.1101/2022.12.19.22283598 — Posted: 2022-12-19
How SARS-CoV-2 alters the regulation of gene expression in infected cells.
Bignon, E., Grandemange, S., Dumont, E., Monari, A.
10.1101/2022.12.18.520908 — Posted: 2022-12-19
Prewhitening and Normalization Help Detect a Strong Cross-Correlation Between Daily Wastewater SARS-CoV-2 RNA Abundance and COVID-19 Cases in a Community
Jeon, M. K., Li, B., Di, D. Y. W., Yan, T.
10.1101/2022.12.16.520829 — Posted: 2022-12-19
High-Throughput Discovery and Characterization of Viral Transcriptional Effectors in Human Cells
Ludwig, C. H., Thurm, A. R., Morgens, D. W., Yang, K. J., Tycko, J., Bassik, M. C., Glaunsinger, B. A., Bintu, L.
10.1101/2022.12.16.520835 — Posted: 2022-12-19
A versatile and interoperable computational framework for the analysis and modeling of COVID-19 disease mechanisms
Niarakis, A., Ostaszewski, M., Mazein, A., Kuperstein, I., Gillespie, M. E., Kutmon, M., Funahashi, A., Acencio, M. L., Hemedan, A., Aichem, M., Klein, K., Czauderna, T., Burtscher, F., Yamada, T. G., Hiki, Y., Hiroi, N. F., Hu, F., Pham, N., Ehrhart, F., Willighagen, E. L., Valdeolivas, A., Dugourd, A., Messina, F., Esteban-Medina, M., Pena-Chilet, M., Rian, K., Soliman, S., Aghamiri, S. S., Puniya, B. L., Naldi, A., Helikar, T., Singh, V., Farinas Fernandez, M., Bermudez, V., Tsirvouli, E., Montagud, A., Noel, V., Ponce de Leon, M., Maier, D., Bauch, A., Gyori, B. M., Bachman, J. A., Luna, A., Pinero, J., Furlong, L., Balaur, I., Rougny, A., Jarosz, Y., Overall, R. W., Phair, R., Perfetto, L., Matthews, L., Rex, D. A. B., Orlic-Milacic, M., Monraz Gomez, L. C., De Meulder, B., Ravel, J. M., Jassal, B., Satagopam, V. P., Wu, G., Golebiewski, M., Gawron, P., Calzone, L., Beckmann, J., Evelo, C., d'Eustachio, P., Schreiber, F., Saez-Rodriguez, J., Dopazo, J., Kuiper, M., Valencia, A., Wolkenhauer, O., Kitano, H., Barillot, E., Auffray, C., Balling, R., Schneider, R., the COVID-19 Disease Map Community
10.1101/2022.12.17.520865 — Posted: 2022-12-19
Evaluation of bivalent Omicron BA.1 booster vaccination after different priming regimens in healthcare workers (SWITCH ON): a randomized controlled trial
Tan, N., Geers, D., Sablerolles, R., Rietdijk, W., Goorhuis, B., Postma, D., Visser, L., Bogers, S., van Dijk, L., Gommers, L., van Leeuwen, L., Boerma, A., Nijhof, S., van Dort, K., Koopmans, M., Dalm, V. A. S. H., Lafeber, M., Kootstra, N. A., Huckriede, A., van Baarle, D., Zaeck, L., GeurtsvanKessel, C., de Vries, R. D., van der Kuy, H.
10.1101/2022.12.18.22283593 — Posted: 2022-12-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).